Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nokitaka Setsu

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Analytical Cellular Pathology (Amsterdam)|July 24, 2018
Class III <i>β</i>-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell LineKenichiro Yahiro, Yoshihiro Matsumoto, Jun-Ichi Fukushi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 13, 2010
Low-grade dedifferentiated liposarcoma of the neck: magnetic resonance imaging and pathological correlationMakoto Endo, Yoshinao Oda, Katsumi Harimaya, et al.
Biomed Research International|August 31, 2017
Metabolic Tumor Volume by <sup>18</sup>F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal TumorsYoshihiro Matsumoto, Shingo Baba, Makoto Endo, et al.
Biomed Research International|August 18, 2017
Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal SarcomaYoshihiro Matsumoto, Makoto Shinoto, Makoto Endo, et al.
Plos One|March 16, 2018
Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumorSuguru Fukushima, Makoto Endo, Yoshihiro Matsumoto, et al.
Plos One|May 31, 2017
Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumorSuguru Fukushima, Makoto Endo, Yoshihiro Matsumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2012
Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumorsMakoto Endo, Hidetaka Yamamoto, Nokitaka Setsu, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|April 22, 2020
Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature reviewNoriko Oyama, Kanako Kojima-Ishii, Naoko Toda, et al.
British Journal of Cancer|January 12, 2022
Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcomaEijiro Shimada, Yoshihiro Matsumoto, Makoto Nakagawa, et al.
Scientific Reports|August 4, 2022
Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of boneAtsushi Kimura, Yu Toda, Yoshihiro Matsumoto, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Analytical Cellular Pathology (Amsterdam)|July 24, 2018
Class III <i>β</i>-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell LineKenichiro Yahiro, Yoshihiro Matsumoto, Jun-Ichi Fukushi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 13, 2010
Low-grade dedifferentiated liposarcoma of the neck: magnetic resonance imaging and pathological correlationMakoto Endo, Yoshinao Oda, Katsumi Harimaya, et al.
Biomed Research International|August 31, 2017
Metabolic Tumor Volume by <sup>18</sup>F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal TumorsYoshihiro Matsumoto, Shingo Baba, Makoto Endo, et al.
Biomed Research International|August 18, 2017
Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal SarcomaYoshihiro Matsumoto, Makoto Shinoto, Makoto Endo, et al.
Plos One|March 16, 2018
Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumorSuguru Fukushima, Makoto Endo, Yoshihiro Matsumoto, et al.
Plos One|May 31, 2017
Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumorSuguru Fukushima, Makoto Endo, Yoshihiro Matsumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2012
Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumorsMakoto Endo, Hidetaka Yamamoto, Nokitaka Setsu, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|April 22, 2020
Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature reviewNoriko Oyama, Kanako Kojima-Ishii, Naoko Toda, et al.
British Journal of Cancer|January 12, 2022
Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcomaEijiro Shimada, Yoshihiro Matsumoto, Makoto Nakagawa, et al.
Scientific Reports|August 4, 2022
Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of boneAtsushi Kimura, Yu Toda, Yoshihiro Matsumoto, et al.
Pageof 8